Official SEC submissions

Crescent Biopharma SEC Filings

Crescent Biopharma (CBIO) SEC filings, periodic reports and insider submissions.

Direct answer

Crescent Biopharma's latest SEC filing is 10-Q.

It was filed on July 30, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.
Official SEC EDGAR submissions

Get free Crescent Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

10-Q/A

Periodic report

Filed:

Report date:

10-Q/A

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

DEFA14A

Proxy statement

Filed:

DEFA14A

Open SEC documentView filing index

DEFA14A

Proxy statement

Filed:

DEFA14A

Open SEC documentView filing index

DEF 14A

Proxy statement

Filed:

Report date:

DEF 14A

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

10-K

Periodic report

Filed:

Report date:

10-K

Open SEC documentView filing index

S-1

Registration statement

Filed:

S-1

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

Verified data

Recent filing categories
5
Recent filings
40
SEC CIK
0001253689
Latest filing date
July 30, 2026

Explore related company data

View the Crescent Biopharma company profileView Crescent Biopharma annual financials